Great news! The NIH/NIGMS will continue to support our endeavors in activity-based DEL screening under the auspices of an R35 MIRA. A major new thrust includes tackling the problem of druggability and, specifically, enabling chemical probe discovery through the use of only one assay (akin to how DNA sequencers work).
defeating druggability, democratizing drug discovery